Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
64
days
Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer
Authors
I-SPY2 Trial Investigators and Advocates; Ciara C. O’Sullivan; Kevin M. Kalinsky; Christina Yau; Tejaswini Kulkarni; Douglas Yee; Anne M. Wallace; A. Jo Chien; Judy C. Boughey; Anthony D. Elias; Rita Nanda; Claudine Isaacs; Coral Omene; Erica Stringer-Reasor; Amy S. Clark; Alexandra Thomas; Heather S. Han; Nancy Chan; Nicole Williams; Meghna S. Trivedi; Mili Arora; Christos Vaklavas; Jennifer Tseng; Satya Bommakanti; Jesus D. Anampa Mesias; Alexandra Zimmer; Carla Falkson; Evanthia Roussos Torres; Chaitali Nangia; Kathy S. Albain; Mariya Rozenblit; Somaye Zare; Soudabeth Fazelli; Yunni-Yi Chen; Laura A. Huppert; An L. Church; Heather Beckwith; Evelyn Carroll; Malvika Solanki; Virginia F. Borges; Sarah E. A. Tevis; Nan Chen; Jay C. Zeck; Maria J. Kowzun; Jessica Sullivan; Natalie Marshall; Molly E. Klein; Karthik V. Giridhar; Radhika Acharya-Leon; Betty Fan; Elaine M. Walsh; Anya Litvak; Nusrat Jahan; Elizabeth McDonald; Emily Hughes Douglas; Jameel Zena; Amber Guth; Kai Johnson; Julia E. McGuinness; Kant Matsuda; Shadi Shakeri; Jairam Krishnamurthy; Irene Kang; Abigail Madans; Sheldon Feldman; Monica Johnson; Hani Katerji; Yangling Ma; Jeffrey B. Matthews; Amy L. Delson; Barbara LeStage; Jane Perlmutter; Emanuel F. Petricoin; Rebecca A. Shatsky; Elissa Price; Amrita Basu; Adam L. Asare; Teresa Helsten; Marisa Howard McNatt; Rita A. Mukhtar; W. Fraser Symmans; Alexander D. Borowsky; Dawn L. Heshman; Angela M. DeMichele; Hope S. Rugo; Nola M. Hylton; Laura J. van ’t Veer; Laura J. EssermanShow moreShow less
Affiliations
1. Mayo Clinic, Rochester, Minnesota; 2. Emory University Winship Cancer Institute, Atlanta, Georgia; 3. University of California, San Francisco; 4. University of Alabama, Birmingham; 5. University of Minnesota, Minneapolis; 6. University of California, San Diego, La Jolla; 7. University of Colorado, Aurora; 8. University of Chicago, Chicago, Illinois; 9. Georgetown University, Washington, DC; 10. Rutgers Cancer Institute of New Jersey, New Brunswick; 11. Cooperman Barnabas Medical Center, Livingston, New Jersey; 12. University of Pennsylvania, Philadelphia; 13. Wake Forest, Winston-Salem, North Carolina; 14. Duke University, Durham, North Carolina; 15. Moffitt Cancer Center, Tampa, Florida; 16. New York University, New York; 17. The Ohio State University, Columbus; 18. Columbia University, New York, New York; 19. UC Davis Health, Sacramento, California; 20. University of Utah Huntsman Cancer Institute, Salt Lake City; 21. City of Hope (Lennar), Duarte, California; 22. Health Partners Institute–Hennepin, Minneapolis, Minnesota; 23. Montefiore Medical Center, New York, New York; 24. Oregon Health and Science University, Portland; 25. University of Rochester Medical Center, Rochester, New York; 26. University of Southern California, Los Angeles; 27. Hoag Family Cancer Institute, Irvine, California; 28. Loyola University Medical Center, Maywood, Illinois; 29. Yale University, New Haven, Connecticut; 30. I-SPY2 Patient Advocates, University of California, San Francisco; 31. Gemini Group, Ann Arbor, Michigan; 32. George Mason University, Fairfax, Virginia; 33. Quantum Leap Healthcare Collaborative, San Francisco, California; 34. MD Anderson, Houston, Texas; 35. City of Hope, Duarte, CaliforniaShow moreShow less
10
days
Federal and Industry Sponsorship in US Cancer Clinical Trials
Authors
Joseph M. Unger; Hong Xiao; Michael L. LeBlanc; Dawn L. HershmanShow moreShow less
Affiliations
1. Fred Hutchinson Cancer Center, Seattle, Washington; 2. Columbia University Irving Medical Center, New YorkShow moreShow less
42
days
Trends in Meningioma Incidence, Treatment, and Imaging Surveillance
Authors
Anders Rosendal Korshøj; Henriette Engberg; Mette Haldrup; Anne Kudsk Ragner; Brian Lind Olsen; Khuozima Azam; Tiit Illimar Mathiesen; Mahmoud Albarazi; David Scheie; Slavka Lukacova; Kåre Schmidt Ettrup; Christian Bonde Pedersen; Jane Skjøth-Rasmussen; Steinbjørn HansenShow moreShow less
Affiliations
1. Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark; 2. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 3. The Danish Healthcare Quality Institute, Odense, Denmark; 4. Department of Neurosurgery, Odense University Hospital, Odense, Denmark; 5. Department of Neurosurgery, Rigshospitalet, København, Denmark; 6. Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark; 7. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 8. Department of Pathology, Rigshospitalet, København, Denmark; 9. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; 10. Department of Neurosurgery, Aalborg University Hospital, Gistrup, Denmark; 11. Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 12. Department of Oncology, Odense University Hospital, Odense, DenmarkShow moreShow less
148
days
Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer
Authors
Maria M. Karsten; Pimrapat Gebert; Therese Pross; Anna M. Hage; Adam D. Dordevic; Susan Stephan; Friedrich Kühn; Lea Doppelbauer; Jens-Uwe Blohmer; Felix Fischer; Matthias Rose; Anna Pöhlmann; Bianca Materne; Morten Aagaard Petersen; Luis Pauler; Julia Ferencz; Simone Wesselmann; Clara Breidenbach; Ulrike Grittner; Christoph KowalskiShow moreShow less
Affiliations
1. Department of Gynecology with Breast Center, Charité–Universitätsmedizin Berlin, Berlin, Germany; 2. Berlin Institute of Health at Charité– Universitätsmedizin Berlin, Berlin, Germany; 3. Institute of Biometry and Clinical Epidemiology, Charité–Universitätsmedizin Berlin, Berlin, Germany; 4. Department of Psychosomatic Medicine and Psychotherapy, Theodor-Wenzel-Werk e.V., Berlin, Germany; 5. Center for Patient-Centered Outcomes Research, Department for Psychosomatic Medicine, Charité–Universitätsmedizin Berlin, Berlin, Germany; 6. Palliative Care Research Unit, Department of Geriatrics and Palliative Medicine GP, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; 7. OnkoZert, Neu-Ulm, Germany; 8. Deutsche Gesellschaft für Allgemein und Viszeralchirurgie e.V., Berlin, Germany; 9. German Cancer Society, Berlin, GermanyShow moreShow less
148
days
Mathematical Biomarkers of Adaptive Therapy Outcomes in Prostate Cancer
Authors
Kit Gallagher; Maximilian A. Strobl; Robert A. Gatenby; Jingsong Zhang; Philip K. Maini; Alexander R. AndersonShow moreShow less
Affiliations
1. Wolfson Centre for Mathematical Biology, Mathematical Institute, Oxford, United Kingdom; 2. Integrated Mathematical Oncology Department, Moffitt Cancer Center, Tampa, Florida; 3. Theory Division, Cleveland Clinic, Cleveland, Ohio; 4. Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom; 5. Department of Life Sciences, Imperial College London, London, United Kingdom; 6. Department of Radiology, Moffitt Cancer Center, Tampa, Florida; 7. Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FloridaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days